Alzheimer's disease & dementia

Less Alzheimer's pathology with angiotensin receptor blocker use

(HealthDay)—In autopsy findings, patients treated with angiotensin receptor blockers (ARBs) show less Alzheimer's disease (AD)-related pathology, according to a study published online Sept. 10 in the Archives of Neurology.

Neuroscience

Five CSF markers differentiate dementia, parkinsonism

(HealthDay)—Levels of five different cerebrospinal fluid (CSF) biomarkers are able to improve differentiation between common dementia and parkinsonian disorders, according to a study published online Aug. 27 in the Archives ...

Neuroscience

Shortened telomere length tied to dementia, mortality risk

(HealthDay) -- Shortened telomere length (TL) is associated with risks for dementia and mortality in a population of older adults, according to a study published online July 23 in the Archives of Neurology.

Neuroscience

Clinical decline in Alzheimer's requires plaque and proteins

According to a new study, the neuron-killing pathology of Alzheimer's disease (AD), which begins before clinical symptoms appear, requires the presence of both amyloid-beta (a-beta) plaque deposits and elevated levels of ...

page 2 from 5